Abstract
Methoxamine is an alpha-adrenergic drug, its unique pharmacokinetics and mechanism of action on alpha-1 receptors lead to consider it, similarly to phenylephrine, as a first-choice drug for treating drug-induced or veno-occlusive priapism. The experience obtained with its use in the management of three cases of priapism lasting over 7 h and one case of sustained rigid erection caused during anesthetic induction are reported.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jara, J., Moncada, I., Bueno, G. et al. Intracavernous methoxamine in the treatment of priapism. Int J Impot Res 10, 257–259 (1998). https://doi.org/10.1038/sj.ijir.3900360
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3900360
Keywords
This article is cited by
-
The incidence and management of priapism in Western Australia: a 16 year audit
International Journal of Impotence Research (2003)
-
Erection and NO override the vasoconstrictive effect of α-adrenergic stimulation in the rat penile vasculature
International Journal of Impotence Research (2001)
